IM Cannabis (IMCC) Competitors $2.90 +0.27 (+10.04%) Closing price 03:39 PM EasternExtended Trading$2.88 -0.03 (-1.03%) As of 04:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IMCC vs. COEP, ALXO, GBIO, TENX, CARA, SNYR, CYTH, BCAB, DARE, and CMMBShould you be buying IM Cannabis stock or one of its competitors? The main competitors of IM Cannabis include Coeptis Therapeutics (COEP), ALX Oncology (ALXO), Generation Bio (GBIO), Tenax Therapeutics (TENX), Cara Therapeutics (CARA), Synergy CHC (SNYR), Cyclo Therapeutics (CYTH), BioAtla (BCAB), Dare Bioscience (DARE), and Chemomab Therapeutics (CMMB). These companies are all part of the "pharmaceutical products" industry. IM Cannabis vs. Its Competitors Coeptis Therapeutics ALX Oncology Generation Bio Tenax Therapeutics Cara Therapeutics Synergy CHC Cyclo Therapeutics BioAtla Dare Bioscience Chemomab Therapeutics Coeptis Therapeutics (NASDAQ:COEP) and IM Cannabis (NASDAQ:IMCC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations. Does the media favor COEP or IMCC? In the previous week, Coeptis Therapeutics had 1 more articles in the media than IM Cannabis. MarketBeat recorded 2 mentions for Coeptis Therapeutics and 1 mentions for IM Cannabis. Coeptis Therapeutics' average media sentiment score of 0.00 equaled IM Cannabis'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Coeptis Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral IM Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders hold more shares of COEP or IMCC? 13.9% of Coeptis Therapeutics shares are held by institutional investors. Comparatively, 7.7% of IM Cannabis shares are held by institutional investors. 24.3% of Coeptis Therapeutics shares are held by insiders. Comparatively, 5.9% of IM Cannabis shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has preferable earnings & valuation, COEP or IMCC? IM Cannabis has higher revenue and earnings than Coeptis Therapeutics. IM Cannabis is trading at a lower price-to-earnings ratio than Coeptis Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCoeptis TherapeuticsN/AN/A-$10.88M-$5.80-1.31IM Cannabis$39.44M0.30-$7.72M-$0.64-4.54 Is COEP or IMCC more profitable? Coeptis Therapeutics has a net margin of 0.00% compared to IM Cannabis' net margin of -9.10%. IM Cannabis' return on equity of -122.96% beat Coeptis Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Coeptis TherapeuticsN/A -282.39% -127.23% IM Cannabis -9.10%-122.96%-11.69% Which has more risk and volatility, COEP or IMCC? Coeptis Therapeutics has a beta of -0.63, indicating that its share price is 163% less volatile than the S&P 500. Comparatively, IM Cannabis has a beta of 2.19, indicating that its share price is 119% more volatile than the S&P 500. SummaryIM Cannabis beats Coeptis Therapeutics on 6 of the 11 factors compared between the two stocks. Get IM Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for IMCC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IMCC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IMCC vs. The Competition Export to ExcelMetricIM CannabisMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.68M$10.51B$5.54B$8.95BDividend YieldN/A2.09%5.38%4.08%P/E Ratio-4.5416.7427.4020.04Price / Sales0.3029.51419.46118.60Price / CashN/A22.8436.6357.47Price / Book2.823.668.085.67Net Income-$7.72M$235.40M$3.16B$248.47M7 Day Performance4.50%1.89%2.12%2.90%1 Month Performance0.87%3.83%4.43%5.75%1 Year Performance3.68%-10.20%35.62%21.36% IM Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IMCCIM Cannabis0.3681 of 5 stars$2.91+10.0%N/A-1.6%$10.68M$39.44M-4.54340COEPCoeptis Therapeutics0.2987 of 5 stars$7.24+2.6%N/A+36.0%$25.40MN/A-1.252Gap UpALXOALX Oncology2.6754 of 5 stars$0.47+2.9%$3.30+597.7%-92.2%$25.26MN/A-0.1940Negative NewsGBIOGeneration Bio2.9836 of 5 stars$0.37+2.8%$7.33+1,882.0%-85.6%$24.87M$24.56M-0.34150TENXTenax Therapeutics1.311 of 5 stars$5.90+4.9%$17.50+196.9%+81.1%$24.46MN/A-2.389CARACara Therapeutics0.372 of 5 starsN/AN/AN/A$24.33M$7.14M-0.2580News CoverageGap DownHigh Trading VolumeSNYRSynergy CHC3.7599 of 5 stars$2.61+1.6%$10.00+283.1%N/A$23.99M$34.83M0.0040CYTHCyclo TherapeuticsN/A$0.72flat$0.95+31.8%N/A$23.72M$870.73K-0.809BCABBioAtla2.5581 of 5 stars$0.40-2.6%$5.00+1,146.9%-69.9%$23.43M$11M-0.3360News CoverageGap DownDAREDare Bioscience1.761 of 5 stars$2.63+2.6%$12.00+357.0%-33.9%$23.24M$10K-15.4530News CoverageCMMBChemomab Therapeutics2.9038 of 5 stars$1.20+1.7%$8.50+608.3%+18.7%$22.63MN/A-1.5820News Coverage Related Companies and Tools Related Companies COEP Competitors ALXO Competitors GBIO Competitors TENX Competitors CARA Competitors SNYR Competitors CYTH Competitors BCAB Competitors DARE Competitors CMMB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IMCC) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IM Cannabis Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share IM Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
